Bioblast Pharma Ltd Stock Nasdaq
Equities
IL0011319527
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 27.28M |
---|---|---|---|---|---|
Net income 2024 * | -16M | Net income 2025 * | -12M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.69
x | P/E ratio 2025 * |
-2.64
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.57% |
Managers | Title | Age | Since |
---|---|---|---|
Oren Hershkovitz
CEO | Chief Executive Officer | 47 | 19-11-15 |
Dror Mevorach
FOU | Founder | 68 | 08-12-31 |
Director of Finance/CFO | 47 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shai Novik
CHM | Chairman | 58 | 19-03-25 |
Avri Havron
BRD | Director/Board Member | 75 | 13-12-31 |
Brian Schwartz
BRD | Director/Board Member | 52 | 20-11-30 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |